Element Science Expands Executive Leadership Team to Accelerate Commercial Growth and Execution
Element Science, a pioneering health technology company and creator of the Jewel® Patch Wearable Cardioverter Defibrillator (Patch-WCD) to monitor and protect patients at high-risk of sudden cardiac arrest (SCA), today announced several strategic appointments to its executive leadership team. These key hires bring extensive industry experience across commercial strategy, operations, finance, and human resources to drive the company's next phase of growth.
Element Science Receives FDA Approval for the Revolutionary Jewel® Patch Wearable Cardioverter Defibrillator
In a significant leap forward in the care of patients with cardiac disease, Element Science is proud to announce that its innovative Jewel® Patch Wearable Cardioverter Defibrillator (Patch-WCD) has received U.S. Food and Drug Administration (FDA) approval of its Premarket Approval (PMA) application. This positive decision paves the way for the Jewel Patch-WCD to offer unparalleled protection for U.S. patients who have an elevated temporary risk of sudden cardiac arrest, revolutionizing the approach to lifesaving wearable therapeutics. The Jewel Patch-WCD received the European Union’s CE mark certification and Great Britain’s UK Conformity Assessed (UKCA) marking in January 2024.
Publication of Strongly Positive Findings Demonstrate Benefits of Innovative Jewel® Patch Wearable Cardioverter Defibrillator for Patients at Risk of Sudden Cardiac Arrest
Element Science, an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients, today announced the publication of its Jewel IDE Study results, conducted in sites across the United States, in the prestigious Journal of the American College of Cardiology (JACC)1 as well the recent publication of its Jewel EP Lab Study, conducted in the European Union, in Europace2. The publication of these positive results underscores the potential impact of the Jewel® Wearable Patch Cardioverter Defibrillator (Jewel) and highlights the value of utilizing truly patient-centric technology when managing patients at risk of sudden cardiac arrest (SCA).
Element Science Receives Prestigious International Red Dot Design Award for Innovative Jewel® Patch Wearable Cardioverter Defibrillator
Element Science, an innovative health technology company pioneering a digital wearable platform that monitors and protects high-risk cardiovascular patients, announces that its Jewel® Wearable Patch Cardioverter Defibrillator (Jewel) has received the prestigious Red Dot Design Award. This award signals international recognition of Jewel's unique design, focusing on patient comfort while delivering continuous protection from temporary periods of elevated Sudden Cardiac Arrest (SCA) risk, which typically occurs in the weeks to months after suffering a cardiac event, such as a heart attack.
Element Science Appoints Lee Smith, Jr. as the Company’s First Head of Commercial
Element Science, an innovative health technology company developing a pioneering digital wearable platform for high-risk cardiovascular patients, announced the appointment of Lee Smith Jr. as the company's first Head of Commercial. With nearly 20 years of successful leadership experience in sales, commercial operations, and customer success, Mr. Smith will be instrumental in driving the launch and expansion of Element Science's Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) globally.
Element Science Receives CE Mark & UKCA Mark for the Jewel® Patch-Wearable Cardioverter Defibrillator
Element Science, an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients, announced that it has received the European Union’s CE mark certification and Great Britain’s UK Conformity Assessed (UKCA) marking for its novel Patch Wearable Cardioverter Defibrillator (P-WCD) from its Notified Body, the BSI Group.
Element Science Announces Presentation of Successful Results of the Jewel® IDE Study in a Featured Science Presentation at the American Heart Association’s 2023 Annual Scientific Sessions
Element Science, an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients, today announced the successful completion and presentation of the results of the Jewel IDE Study. This study of the Jewel Patch-Wearable Cardioverter Defibrillator (P-WCD), which enrolled 305 patients, marks a significant milestone in the field of sudden cardiac arrest (SCA) protection.
Element Science Adds Kathy Jeffery as Chief People Officer
Element Science, an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients transitioning from hospital to home, announced that Kathy Jeffery has joined as the Company’s first Chief People Officer (CPO).
Element Science Announces First Patient Save with Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)
Element Science, an innovative health technology company pioneering a next-generation digital wearable platform for high-risk cardiovascular patients transitioning from hospital to home, today announced the first patient save from a successful defibrillation early in the enrollment of the Investigational Device Exception (IDE) Study of its Jewel Patch Wearable Cardioverter Defibrillator (P-WCD). The Jewel P-WCD is a low-profile wearable defibrillator designed to detect and treat life-threatening arrhythmias in patients with a high temporary risk for Sudden Cardiac Arrest (SCA), a condition that affects more than 500,000 patients in the US annually.
